| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/13/1997 | CA2230557A1 Interactive molecular conjugates |
| 03/13/1997 | CA2230477A1 Use of a thienotriazolodiazepine to increase apolipoprotein a-i levels |
| 03/13/1997 | CA2230385A1 Analogs for specific oliogosaccharide-neuregulin interactions and uses thereof |
| 03/13/1997 | CA2230362A1 Optically active phenyl pyrimidine derivative as analgesic agent |
| 03/13/1997 | CA2229036A1 Substituted phosphinic compounds and their use as pharmaceuticals |
| 03/13/1997 | CA2228898A1 An agent for inhibiting carcinogenesis |
| 03/13/1997 | CA2228667A1 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 03/13/1997 | CA2228647A1 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings |
| 03/13/1997 | CA2228632A1 Cycloanthelmintic inhibitors |
| 03/13/1997 | CA2228003A1 2-deoxystreptamine as a molecular scaffold for preparing functionally and spatially diverse molecules and pharmaceutical compositions thereof |
| 03/13/1997 | CA2228002A1 Novel carboxylic acid derivatives, their preparation and use |
| 03/13/1997 | CA2227301A1 Hcv binding protein |
| 03/13/1997 | CA2224874A1 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 03/13/1997 | CA2204007A1 Remedy for diseases caused by infection with helicobacter |
| 03/13/1997 | CA2184971A1 Cephalosporin derivatives |
| 03/13/1997 | CA2184316A1 Buccal delivery system for therapeutic agents |
| 03/12/1997 | EP0761672A1 Cephalosporin containing in position 7 a substituted benzyloxyimino radical, processes for their preparation and intermediates for their preparation, their use as medicaments |
| 03/12/1997 | EP0761671A1 Cephem derivatives |
| 03/12/1997 | EP0761669A2 Pentacyclic compounds, intermediates, processes, compositions, and methods |
| 03/12/1997 | EP0761668A2 Non-classical antifolates |
| 03/12/1997 | EP0761667A1 Heterocyclic substituted pseudopeptides |
| 03/12/1997 | EP0761666A2 Antidepressant 1-arylalkyl-4-(alkoxypyridinyl)- or 4-(alkoxypyrimidinyl)piperazine derivatives |
| 03/12/1997 | EP0761661A1 Glycomimetics as selectin antagonists, and anti-inflammatory agents prepared thereof |
| 03/12/1997 | EP0761659A1 Naphthyl and dihydronaphthyl compounds as medicaments |
| 03/12/1997 | EP0761656A1 Alternate crystal form of tazofelone ((+,-)-5-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methyl)-4-thiazolidinone) |
| 03/12/1997 | EP0761651A2 Process for preparing optically active ortho-substituted 4-aryl-dihydropyridines |
| 03/12/1997 | EP0761650A1 Thermally stable and storable crystalline modification of N-methyl-N-((1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)-ethyl)-2,2-diphenyl-acetamide and process for its preparation |
| 03/12/1997 | EP0761644A2 Amide derivatives and their use in cosmetic composition |
| 03/12/1997 | EP0761234A2 Pharmaceutical combined preparation with ketoprofen |
| 03/12/1997 | EP0761226A1 Method of potentiating antibiotics with polyphenols |
| 03/12/1997 | EP0761225A1 Pharmaceutical composition for treating peripheral circulation disorder |
| 03/12/1997 | EP0761224A1 Use of orotic acid for the preparation of a medicament for preventing or treating the remodelling in patients suffering from acute myocardial infarction |
| 03/12/1997 | EP0761223A1 Use of orotic acid for the preparation of a medicament for treating patients suffering from serious heart failure with indication of heart transplantation |
| 03/12/1997 | EP0761222A1 Use of orotic acid for the preparation of a medicament for amelioration of microcirculation |
| 03/12/1997 | EP0761221A1 Use of orotic acid for the preparation of a medicament for prophylaxis and therapy of metabolic syndrom |
| 03/12/1997 | EP0761220A1 2-Acylaminopropanamides as growth hormone secretagogues |
| 03/12/1997 | EP0761219A1 2-Acylaminopropanamines as growth hormone secretagogues |
| 03/12/1997 | EP0761218A1 Process for preparing polymer coated tablet comprising amoxycillin and clavunalate |
| 03/12/1997 | EP0761217A1 Ready-to-use eye lotion containing indomethacin |
| 03/12/1997 | EP0761216A1 Rhodamine 123 compositions and methods for treating prostate cancer |
| 03/12/1997 | EP0761215A1 Antibacterial agent |
| 03/12/1997 | EP0761214A2 N,N-disubstituted anilines or alkylamines as singlet oxygen quenchers, topical compositions comprising them |
| 03/12/1997 | EP0761211A1 Sustained release composition |
| 03/12/1997 | EP0761210A2 Process for the manufacture of pharmaceutical preparations with controlled release |
| 03/12/1997 | EP0761209A2 Controlled release formulations of ranitidine |
| 03/12/1997 | EP0761208A1 Process for preparing dry pharmaceutical forms and compositions thus made |
| 03/12/1997 | EP0761207A2 Oral pharmaceutical preparations containing antacids |
| 03/12/1997 | EP0761203A1 Use of cysteine acid homocysteine for enhancing the desquamation of the skin or to stimulate the renewal of the epidermis |
| 03/12/1997 | EP0761095A2 A new skin preparation composition |
| 03/12/1997 | EP0760820A1 Cephalosporin compounds and processes for the preparation thereof |
| 03/12/1997 | EP0760819A1 Tricyclic dicarbonyl derivatives |
| 03/12/1997 | EP0760818A1 Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 03/12/1997 | EP0760815A1 Processes for preparing 1-butyl-2-[2'-(2h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1h-indole-3-carboxylic acid |
| 03/12/1997 | EP0760814A1 A process for preparing 1-butyl-2-[2'-(2h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1h-indole-3-carboxylic acid |
| 03/12/1997 | EP0760813A1 Inhibitors of farnesyl-protein transferase |
| 03/12/1997 | EP0760812A1 Pharmaceutical diketopiperazine compounds |
| 03/12/1997 | EP0760811A1 Imidazole derivatives as histamine receptor h 3? (ant)agonists |
| 03/12/1997 | EP0760680A1 Pharmaceutical composition |
| 03/12/1997 | EP0760675A1 Compositions comprising dna damaging agents and p53 |
| 03/12/1997 | EP0760668A1 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 03/12/1997 | EP0760667A1 Cancer treatment and metastasis prevention |
| 03/12/1997 | EP0760666A1 Use of oligonucleotide phosphorothioate for depleting complement and for reducing blood pressure |
| 03/12/1997 | EP0760665A1 COMPOSITION CONTAINING 5HT IA? and 5HT ID? ANTAGONISTS |
| 03/12/1997 | EP0760664A1 Use of pteridine derivatives as no-synthase inhibitors |
| 03/12/1997 | EP0760663A1 Use of a 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole derivative for treating allergic conjunctivitis |
| 03/12/1997 | EP0760661A1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 03/12/1997 | EP0760660A1 Treating conditions using optically pure(-)-liarozole |
| 03/12/1997 | EP0760659A1 Applying alpha hydroxy acids for striae distensae |
| 03/12/1997 | EP0760658A1 Compounds for inhibiting osteoclast-mediated bone resorption |
| 03/12/1997 | EP0760657A1 Novel potent inducers of terminal differentiation and methods of use thereof |
| 03/12/1997 | EP0760656A1 Transdermal delivery of anti-epileptic drugs |
| 03/12/1997 | EP0760650A1 Antimicrobial oil-in-water emulsions |
| 03/12/1997 | EP0760649A1 Fluticasone propionate formulations |
| 03/12/1997 | EP0760648A1 Chewable flubendazole tablets for companion animals |
| 03/12/1997 | EP0760601A1 Predicting fetal membrane rupture by mmp-9 activity |
| 03/12/1997 | EP0696289B1 Benzo[f]quinoxalindione derivatives, their preparation and their use in drugs |
| 03/12/1997 | EP0693059B1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same |
| 03/12/1997 | EP0686036B1 Use of prostane derivatives of formulae i and ii for the production of a medicament for the treatment of chronic polyarthritis |
| 03/12/1997 | EP0680319B1 Nitroglycerine-containing plaster, process for producing the same and its use |
| 03/12/1997 | EP0673378B1 New triazolopyrimidones, their preparation and their use |
| 03/12/1997 | EP0665830B1 Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it |
| 03/12/1997 | EP0648207B1 Vitamin d analogues |
| 03/12/1997 | EP0646006B1 Gastro-protected stable omeprazole compositions in the form of microgranules and process for their production |
| 03/12/1997 | EP0644873B1 Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives |
| 03/12/1997 | EP0636137B1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 03/12/1997 | EP0627919B1 Application of 2-amino 6-trifluoromethoxy benzothiazole (riluzole) for obtaining a drug useful in the treatment of motor neuron diseases |
| 03/12/1997 | EP0627001A4 Mammalian sos - a regulator/effector of tyrosine kinase signalling. |
| 03/12/1997 | EP0618900B1 Substituted tetrahydroisoquinolines and their use as therapeutic agents |
| 03/12/1997 | EP0618798B1 Pyridylguanidine compounds for treatment of erectile dysfunction |
| 03/12/1997 | EP0616529B1 Drug formulations for parenteral use |
| 03/12/1997 | EP0599908B1 New ganglioside derivatives |
| 03/12/1997 | EP0592571B1 1,2,4-THIADIAZINO[3,4-b]BENZOTHIAZOLE DERIVATIVES, THEIR PREPARATION, AND DRUGS CONTAINING SAME |
| 03/12/1997 | EP0586518B1 Cholesterol-lowering tocopherol analogs |
| 03/12/1997 | EP0565587B1 THE EFFECT OF N,N,N-TRIMETHYLSPHINGOSINE ON PROTEIN KINASE-C ACTIVITY; MELANOMA CELL GROWTH $i(IN VITRO); METASTATIC POTENTIAL $i(IN VIVO) AND HUMAN PLATELET AGGREGATION |
| 03/12/1997 | EP0561876B1 Use of angiotensin ii receptor antagonists in the treatment of atheroma |
| 03/12/1997 | EP0471040B1 Use of cromakalim/brl 38227 for the treatment of hyperreactivity of airways |
| 03/12/1997 | EP0468997B1 Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
| 03/12/1997 | EP0422100B1 11 beta-substituted progesterone analogs |
| 03/12/1997 | EP0409940B1 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
| 03/12/1997 | CN1145075A Antagonist's of endothelin receptors |